SINGLE ARM NCRI FEASIBILITY PHASE II STUDY OF CHOP IN COMBINATION WITH OFATUMUMAB IN INDUCTION AND MAINTENANCE FOR PATIENTS WITH NEWLY DIAGNOSED RICHTER'S SYNDROME
J Gribben , P Hillmen , T Eyre , L Boyle
Haematologica 100 109 -109
1
2015
LINKING PROTEOME AND GENOME FOR BIOMARKER DISCOVERY IN CLL-ESTABLISHMENT OF A CLL PROTEIN DATABASE
N Kitteringham , P Hillmen , A Pettitt , M Oates
Haematologica 101 420 -421
2016
IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONS
A Pellagatti , V Steeples , E Sharma , E Repapi
Haematologica 102 12 -12
2
2017
Atypical congenital dyserythropoietic anaemia: a novel mutation in LPIN2 causes Majeed syndrome with incomplete penetrance
S McGowan , D Ferguson , G Hall , D Roberts
British Journal of Haematology 161 11 -11
2013
The Effects of Cold Ischaemia on Tumour Morphology and DNA Quality for Whole Genome Sequencing: A Systematic Comparative Study of a Series of Renal Tumours in a Single Institution
C Verrill , R T Colling , E Collantes , Roberts Isd.
The Journal of Pathology 243
2017
10 YEARS EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES
H Dreau , L Foroni , G Vallance , T Littlewood
Haematologica 99 341 -341
2014
JUVENILE HAEMOCHROMATOSIS MUTATIONS ARE NOT THAT SIMPLE
K Robson , P Bignell , A Schuh
American Journal of Hematology 88
2013
COMPREHENSIVE GENETIC TESTING IS REQUIRED FOR PATIENTS WITH UNEXPLAINED IRON OVERLOAD
A Merryweather-Clarke , K Robson , P Bignell , A Schuh
American Journal of Hematology 88
2013
NOVEL GENE DELETIONS RESULT IN HAEMOCHROMATOSIS
S Knight , K Robson , P Bignell , A Schuh
American Journal of Hematology 88
2013
ESTIMATING DISEASE PENETRANCE IN P.C282Y HOMOZYGOTES IN THE UK
A Merryweather-Clarke , K Robson , P Bignell , A Schuh
American Journal of Hematology 88
2013
A NOVEL TMPRSS6 MUTATION IN 2 BULGARIAN SIBLINGS
K Robson , P Bignell , A Schuh , M Sheikh
American Journal of Hematology 88
2013
RARE INHERITED ANAEMIAS: A CLINICAL-GRADE VALIDATED TARGETED RESEQUENCING PANEL YIELDS HIGH DIAGNOSTIC RATES AND IMPROVES TARGETED MANAGEMENT
H Dreau , J Curtin , S Henderson , G Hall
Haematologica 100 292 -293
2015
THE USE OF NEXT-GENERATION SEQUENCING TO SCREEN FOR MUTATIONS IN 16 GENES INVOLVED IN IRON HOMEOSTASIS AS AN AID TO GENETIC DIAGNOSIS FOR PATIENTS WITH IRON OVERLOAD OR IRON DEFICIENCY
K Robson , P Bignell , A Schuh , A Burns
American Journal of Hematology 88
2013
A GENOMEWIDE ASSOCIATION STUDY IDENTIFIES NOVEL LOCI THAT PREDISPOSE TO MYELOPROLIFERATIVE NEOPLASMS
P Guglielmelli , R Kralovics , K Zoi , D Oscier
Haematologica 98 221 -222
2013
Two unusual cases of type 2N von Willebrand disease
N Curry , J Beavis , S Henderson , A Schuh
Journal of Thrombosis and Haemostasis 13 738 -738
2015
The use of next-generation sequencing to screen for disorders of coagulation using a 24 gene panel
D Keeling , N Curry , P Giangrande , J Mason
Journal of Thrombosis and Haemostasis 13 499 -500
2015
Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD eradication after 6 months of combination therapy
J Gribben , A Mccaig , P Hillmen , A Pettitt
British Journal of Haematology 181 34 -35
2018
Understanding the cellular function of SAMHD1: from HIV restriction to tumor suppression
Lin Y-L. , Judde J-G. , P Pasero , T Louis
FEBS Journal 281 768 -768
2014
RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF IDELALISIB (IDELA) IN COMBINATION WITH OFATUMUMAB (OFA) FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
N Wagner-Johnston , J A Garcia-Marco , F Bosch , A Nathwani
Haematologica 100 229 -229
3
2015
Results of the randomised phase II NCRI arctic (attenuated dose rituximab with chemotherapy in CLL) trial of low dose rituximab in previously untreated CLL
D Allsup , L McParland , W Gregory , A Duncombe
British Journal of Haematology 165 54 -55
2014